Advertisement
Research ArticleArticle

Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro

David Pearson, H. Markus Weiss, Yi Jin, Jan Jaap van Lier, Veit J. Erpenbeck, Ulrike Glaenzel, Peter End, Ralph Woessner, Fabian Eggimann and Gian Camenisch
Drug Metabolism and Disposition July 2017, 45 (7) 817-825; DOI: https://doi.org/10.1124/dmd.117.075358

Article Information

vol. 45 no. 7 817-825
DOI 
https://doi.org/10.1124/dmd.117.075358
PubMed 
28442499
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 2, 2017
  • Accepted April 20, 2017
  • Published online June 9, 2017.

Article Versions

Copyright & Usage 
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. David Pearson,
  2. H. Markus Weiss,
  3. Yi Jin,
  4. Jan Jaap van Lier,
  5. Veit J. Erpenbeck,
  6. Ulrike Glaenzel,
  7. Peter End,
  8. Ralph Woessner,
  9. Fabian Eggimann, and
  10. Gian Camenisch
  1. Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland (D.P., H.M.W., Y.J., V.J.E., U.G., P.E., R.W., F.E., G.C.); PRA International, Early Development Services, Zuidlaren, the Netherlands (J.J.v.L.)
  1. Address correspondence to:
    Dr. David Pearson, Pharmacokinetics Sciences, Novartis Institutes for Biomedical Research, Postfach, CH-4002 Basel, Switzerland. E-mail: david.pearson{at}novartis.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20171675651
Sep 20171573259
Oct 20171252741
Nov 20171722338
Dec 20172001826
Jan 20181132927
Feb 20181331731
Mar 20181611346
Apr 20182002657
May 20181461554
Jun 2018293148
Jul 201864833
Aug 201895044
Sep 2018113637
Oct 2018108438
Nov 2018109555
Dec 201878129
Jan 2019108864
Feb 2019136345
Mar 2019216857
Apr 2019114676
May 201974533
Jun 201974831
Jul 201964848
Aug 201955045
Oct 201983936
Nov 201965341
Dec 2019104121
Jan 202093042
Feb 2020103921
Mar 202042623
May 202012120
Jun 2020122727
Jul 202013123
Aug 202012016
Sep 2020733103
Oct 202032623
Nov 202033427
Dec 202034032
Jan 202152940
Feb 2021710128
Mar 202173523
Apr 202135823
May 202135321
Jun 202142110
Jul 202132425
Aug 202142422
Sep 202134031
Oct 202122237
Nov 202124542
Dec 202134211
Jan 202223318
Feb 202233130
Mar 202212723
Apr 202212412
May 202203320
Jun 202223536
Jul 202282750
Aug 202214815
Sep 202215825
Oct 202212922
Nov 202213029
Dec 202261722
Jan 202331615
Feb 202332325
Mar 202332017

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Fevipiprant ADME in Healthy Volunteers and In Vitro

David Pearson, H. Markus Weiss, Yi Jin, Jan Jaap van Lier, Veit J. Erpenbeck, Ulrike Glaenzel, Peter End, Ralph Woessner, Fabian Eggimann and Gian Camenisch
Drug Metabolism and Disposition July 1, 2017, 45 (7) 817-825; DOI: https://doi.org/10.1124/dmd.117.075358
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement